Wassim McHayleh

Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases

Sheikh Asim Ali, Wassim McHayleh, Asif Ahmad et al. · Journal of neurosurgery · 2008 · 84 citations

Medicine, Oncology, Surgery +16

Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the randomized phase 3 ASCENT-04/KEYNOTE-D19 study.

Sara M. Tolaney, Evandro de Azambuja, Kevin Kalinsky et al. · Journal of Clinical Oncology · 2025 · 50 citations

Medicine, Oncology, Pharmacology +14

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer

Sara M Tolaney, E. de Azambuja, Kevin Kalinsky et al. · New England Journal of Medicine · 2026 · 29 citations

Medicine, Oncology, Pharmacotherapy +17

Gemtuzumab ozogamicin as first‐line treatment in patients aged 70 years or older with acute myeloid leukemia

Wassim McHayleh, Kenneth A. Foon, Robert L. Redner et al. · Cancer · 2010 · 12 citations · Full text

Medicine, Hematology, Oncology +17

Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin

Wassim McHayleh, Rajesh Sehgal, Robert L. Redner et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 11 citations

Medicine, Oncology, Pharmacology +16